Donepezil can slow the heart rate and, in some cases, disrupt the heart's electrical signaling. A person taking donepezil who develops a slow heartbeat, faints, or has chest pain should call a clinician immediately or seek emergency medical care. A slow heart rate is called bradycardia. It deserves prompt attention during donepezil treatment, even when the person has no known heart condition.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why can donepezil affect the heart?
- Which warning signs need immediate attention?
- Who may be affected?
- Which other medicines matter?
- Does the timing of symptoms matter?
- What does the research show?
Why can donepezil affect the heart?
donepezil is a cholinesterase inhibitor. Its effects can slow electrical signaling at the sinoatrial and atrioventricular nodes, which help control how the heart beats.
The official U.S. label warns that this effect can cause bradycardia or heart block, a problem with electrical signals moving through the heart. It also notes that fainting has been reported in people taking donepezil.
Which warning signs need immediate attention?
According to MedlinePlus, contact a clinician immediately or obtain emergency medical treatment if the person: These signs should not be dismissed as an expected part of dementia or aging. MedlinePlus specifically identifies all three as serious symptoms during donepezil treatment.
- Develops a slow heartbeat
- Faints
- Has chest pain
Who may be affected?
Bradycardia and heart block can occur in people with or without a previously recognized heart-conduction problem. The absence of known heart disease therefore does not rule out a donepezil-related concern.
Before or during treatment, tell the prescriber about heart disease or any irregular, unusually slow, or unusually fast heartbeat. This information helps the prescriber assess new symptoms in context.
Which other medicines matter?
Make sure the prescriber knows about every heart medicine the person takes. NHS guidance specifically names amiodarone, atenolol, bisoprolol, digoxin, and verapamil among medicines that can increase the risk of donepezil side effects when taken together.
This does not establish that a particular drug combination caused a slow heartbeat. It does mean the full medication list is important when a clinician evaluates the problem.
Does the timing of symptoms matter?
Donepezil is generally started at 5 mg daily. The 10 mg dose is deferred for four to six weeks, while 23 mg is deferred until the person has taken 10 mg for at least three months.
Report new warning signs promptly whenever they occur, but pay particular attention after treatment begins or the dose increases. Tell the clinician when the symptoms started and whether they followed a dose change.
What does the research show?
An observational study of adults aged 67 or older found that recent cholinesterase-inhibitor initiation was associated with more than twice the odds of hospitalization for bradycardia. Donepezil accounted for 73% of the analyzed cases.
The study cannot prove that the medicine caused each hospitalization, and it examined the drug class rather than donepezil alone. However, similar associations appeared among people with existing cardiac disease and those using heart-rate-slowing medicines in the PLOS Medicine analysis.
